Catalyst Bioconsulting Mission
Who We Are
Catalyst consultants are postdoctoral researchers, staff, and graduate students from diverse backgrounds currently working in various fields of academic research.
As scientists and medical professionals, Catalyst consultants are specially trained to strategically and methodically find solutions to complex problems, interpret and organize data and communicate the relevant findings to interested stakeholders.Β
Types of Services
Using a team-based approach, Catalyst Bioconsulting provides short term consulting services for the complex challenges faced by start-up and second-stage firms. Our consultants are highly skilled in conducting rigorous research and filtering through complex issues to formulate objective, research-based recommendations. Each team is made up of 2-3 consultants that will address the needs of your company. Projects are typically completed within 2-4 months with each team member committing 5-10 hours per week. There is no fee for our services. Past projects have included:
β’ Business plan drafting
β’ Company valuation
β’ Competitive benchmarking
β’ FDA regulatory assessment
β’ Identification of in- and out-licensing partner companies
β’ Market research analysis
β’ Price sensitivity analysis
β’ Product commercialization
β’ Product packaging
β’ Targeted surveys
β’ SBIR grant preparation
Past Clients
Catalyst BioConsulting works with companies, large and small, on projects that have the potential to impact company growth and development. We are proud to have worked with these clients and more.
Catalyst BioConsulting Testimonials
βReNeuroGen LLC is a virtual pharmaceutical company developing drug candidates for neurological disorders such as Stroke, Traumatic Brain Injury and Multiple Sclerosis. We have close ties to the ³ΙΘΛΏμΚΦ (³ΙΘΛΏμΚΦ) since one of our co-founders, Dr. Kirkwood Pritchard is also a Professor at this institution. We worked with two different Catalyst BioConsulting [formerly known as PICO] teams on both ischemic stroke and multiple sclerosis projects in our first year of existence. Everybody, from the Director of the Catalyst BioConsulting program, team leaders and team members were truly superb in terms of responsiveness, clarity of thinking, effort and helpfulness. In particular, the Catalyst BioConsulting team contributions for the ischemic stroke project led to additional, novel insights into the science and business model being developed by the Company. ³ΙΘΛΏμΚΦ should be truly proud of such an innovative entrepreneurial program and any health, life science or biotech company looking for augmentive consulting help should strongly consider utilizing Catalyst BioConsulting services and its creative and hard working team members.β
Dr. Stephen Naylor, Co-Founder & CEO, Reneurogen LLC
βWe are a small organization, so a couple of extra people never hurts. Itβs outside, fresh ideas to say, βHey have you thought about thisβ or βHave you thought about thatβ. Just getting more people looking at the same problem who will get to a better answer, sooner.ββ[They are] high energy people, theyβre observant, theyβre smart, theyβre engaged. And I think part of this programβs success is that they have people who fit well into these types of environments.β
Dr. Chad Beyer, senior vice president of research and development, Promentis Pharmaceuticals
CTSI Discovery Radio interview, aired January 19, 2018
Frequently Asked Questions
Health Research Center, H2200
³ΙΘΛΏμΚΦ
8701 Watertown Plank Rd.
Milwaukee, WI 53226
